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Abstract
Recent technological advances have led to an explosion in the system-wide profiling of biological 
processes in the study of herpesvirus biology, herein referred to as “-omics”. In many cases these 
approaches have revealed novel virus-induced changes to host cell biology that can be targeted 
with new antiviral therapeutics. Despite these successes, -omics approaches are not widely applied 
in the study of roseoloviruses. Here we describe examples of how -omics studies have shaped our 
understanding of herpesvirus biology, and discuss how these approaches might be used to identify 
host and viral factors that mediate roseolovirus pathogenesis.
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Introduction
Over the past several years, advancements in high-throughput systems biology approaches 
and technologies have resulted in major vertical achievements in the field of molecular 
biology. For the purpose of this review, omics refers to a systems biology approach for 
defining the components of a biologicial system and their interactions with one another. 
Common examples of -omics approaches include (but are not limited to) functional 
genomics, transcriptomics, metabolomics, and proteomics (reviewed in (1). These 
approaches have been successfully applied to several herpesviruses including human 
herpesvirus 8 (HHV8; also known as Kaposi’s sarcoma-associated herpesvirus or KSHV), 
herpes simplex virus (HSV), human cytomegalovirus (HCMV) and murid herpesvirus 4 
(MuHV4; also known as murine gammaherpesvirus-68 or MHV-68) which are discussed 
below. In each case these studies have vastly expanded our understanding of the unique 
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biology of herpesvirus-infected cells. The unbiased nature of -omics studies has led to a 
wealth of innovative, testable hypotheses and identified novel virus-induced changes to host 
signaling pathways that impact viral replication and subsequent pathogenesis. While 
genomic and transcriptomic studies have identified new herpesvirus coding regions and 
transcripts, metabolomics and proteomics studies have defined novel interactions between 
viruses and host metabolic pathways and protein complexes. While each of these approaches 
alone provides a wealth of information, integrating the various -omics approaches generates 
a holistic understanding of the host-pathogen interactome.
In contrast to the other herpesviruses, few if any -omics approaches have been applied to the 
study roseoloviruses, comprised of human herpesviruses 6A, 6B and 7. It is now feasible to 
apply most, if not all, of the standard -omics approaches to the study of roseoloviruses. In 
this review we highlight opportunities for -omics approaches to rapidly advance our 
understanding of rosoleovirus biology and describe critical unmet research needs where –
omics approaches should prove useful.
Functional Genomics
Functional genomics encompasses the fields of genome sequencing, comparative analysis of 
related genomes, and screening of phenotypic changes within an organism upon disruption 
of a candidate open reading frame (ORF). Within a decade after the first roseolovirus 
genome was discovered in 1986 (2), representative genomes of HHV-6A, HHV-6B and 
HHV-7 were sequenced (Accession #s NC_001664, AF_157706 and U43400 respectively). 
Since the original sequencing of these viruses, additional full-length genomes were reported 
(3–7). Due to distinct characteristics of these viruses including cellular and tissue tropism, 
genomic arrangement, peptide coding capacity and subsequent pathogenesis (8, 9), each of 
these roseoloviruses are classified as separate viruses (10). These studies were the first 
examples of an -omics approach in the study of roseoloviruses. In silico analyses revealed 
roseolovirus coding regions conserved across herpesvirus families, conserved amongst 
roseoloviruses, and most importantly, those unique to each roseolovirus (3–5). For many 
roseolovirus genes, putative functions were inferred based on homology to orthologous 
herpesvirus genes of known function. In addition these analyses allowed for focus on novel 
ORFs that may be involved in distinct roseolovirus pathogenesis. These studies provided the 
first insights into the organization and potential functional capacity of roseoloviruses.
Subsequent functional genomics studies have predominantly employed reverse genetics 
approaches, identifying phenotypic changes resulting from mutation or deletion of a specific 
viral ORF. These studies have almost exclusively focused on HHV-6A, as it is the only 
roseolovirus genome that has been cloned into a bacterial artificial chromosome (BAC) (11) 
and is therefore applicable to genetic manipulation. Examples of reverse genetic approaches 
in roseoloviruses include defining the role of viral glycoproteins in replication (11), and 
confirming the role of homologous genes conserved across the herpesvirus family (12).
Several additional functional genomics approaches have been successfully used in other 
herpesviruses and are amenable to the study of roseoloviruses. While only a handful of 
roseolovirus genomes have been sequenced, multiple full-length genome sequences are 
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available for many other human herpesviruses. Comparison of the coding capacity of 
multiple strains has led to a better understanding of both virus evolution and replication (13). 
An excellent example is HCMV, where clinical strains were found to contain approximately 
15 kb of DNA that is deleted or inverted during laboratory passage thereby altering the 
growth and tropism of these strains (14). Only upon additional sequencing of clinical 
isolates was it found that these alterations resulted in the loss-of-function of 
cytomeglaovirus genes essential for viral latency (15). Presumably roseoloviruses display a 
similar degree of heterogeneity, however this hypothesis has not been tested. The 
widespread availability of next generation sequencing coupled with advances in genome 
analysis and assembly makes this an attractive area for future roseolovirus studies.
Forward genetics approaches have also proven useful in defining novel functions for 
herpesvirus genes. Forward genetics refers to the process of screening random mutants for a 
specified phenotype. Subsequent genotyping of the selected variants then reveals the 
underlying gene (or genes) controlling the phenotype. Many herpesviruses including 
HCMV, HSV1, and MuHV4 have used genome-wide forward genetics studies to 
characterize viral genes. Libraries of expression vectors containing herpesvirus ORFs have 
proven useful in forward genetic screens to identify novel functions for viral genes, 
including antagonism of the host antiviral response (16) and manipulation of the cell cycle 
(17). In addition, global mutagenesis approaches have identified genes in MuHV4 (18), 
MCMV (19) and HCMV (20, 21) needed for efficient virus replication. A global 
determination of the complement of HHV-6A coding regions required for replication should 
be employed to identify novel targets for antiviral drugs. Similarly, a comprehensive 
collection of expression vectors for roseolovirus genes would allow for the identification of 
viral genes that contribute to unique aspects of the roseolovirus life cycle, for example 
genome integration. While HHV-6A, -6B and HHV-7 genomes have each been annotated, 
the field is hampered by a lack of BAC constructs for HHV-6B and HHV-7, thus making the 
essential development of forward genetics screens currently unavailable.
Transcriptomics
The most common, and often first employed, analysis of viral infection is monitoring 
changes in both viral and cellular transcription. High throughput qualitative profiling of 
transcript changes often relies on microarray technologies where one can monitor literally 
thousands of cellular transcripts or complete annotated viral transcripts in a single 
experiment. This technology has been used successfully to study the kinetics of both 
HHV-6A and -6B transcription (22, 23). This powerful resource is important for identifying 
the timing and relative levels of transcription from the viral genome. However, this 
methodology lacks absolute quantification and is biased towards regions of the genome that 
are previously known to be transcribed, as predefined probe sets are used as bait for 
transcripts. Next generation sequencing approaches can be used to address these 
deficiencies. These approaches allow for the unbiased profiling of both cellular and viral 
transcripts at saturating levels, thereby providing insight into both the absolute levels of 
transcripts and also transcript structure (reviewed in (24). While RNA based deep 
sequencing has identified roseolovirus transcripts in a few patient samples (25, 26), and 
RNA based deep sequencing has been used to identify small non-coding RNAs encoded by 
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HHV-6B (27), a targeted approach to define roseolovirus mRNAs in a controlled infection 
has surprisingly not yet been performed. Such an approach would likely refine our 
understanding of the temporal expression of rosoleovirus genes, and potentially identify 
novel coding regions of the viral genome.
Alternative approaches to next generation RNA sequencing have been used with success for 
other herpesviruses including reverse transcriptase coupled real time quantitative PCR (RT-
qPCR) whole genome panels (e.g. (28)) as well as the use of tiled arrays (e.g. (29)). The use 
of a tiled array for the related herpesvirus MuHV4 allowed for highly reproducible 
quantitative and qualitative resolution (20nt) of viral transcription during both lytic 
replication and reactivation from latency (29). In this study, not only were the kinetics of 
viral transcription assessed but the authors identified a previously undefined ORF that was 
not characterized by in silico analysis, underscoring the need for multiple –omics 
approaches for roseolovirus studies. Each of these above mentioned technologies are readily 
applicable and necessary for understanding the viral lifecycle of roseoloviruses and thus 
should be prioritized.
Proteomics
Proteomics concerns the large-scale study of structure, modification, function and 
abundance of proteins. Once a rarity, proteomics approaches have become increasingly 
common in the study of herpesviruses, specifically in defining viral protein function. Many 
herpesvirus proteins bear little or no homology to cellular proteins, limiting the ability to 
infer functional roles based on amino acid sequence conservation. However defining the 
interacting partners for viral proteins in the context of infection is an effective means for 
identifying potential functional roles. Typically this approach involves generating a virus 
strain in which the protein of interest is fused to an epitope tag. The “tagged” viral protein is 
then affinity purified from infected cells lysates, and the associated host and/or viral proteins 
are identified by mass spectrometry (30). This approach has been used successfully to define 
novel functions for numerous herpesvirus proteins (e.g. (31–33), although it has yet to be 
extended to the study of roseolovirus protein functions.
A related approach can be used to identify changes in post-translation modifications (PTMs) 
of host and viral proteins during infection. Antibodies to a specific PTM are used as an 
affinity reagent, and the resulting immune complexes are analyzed by mass spectrometry. 
This approach is especially useful in defining changes in signaling pathways caused by 
infection. For example, phospho-proteomic analysis of MuHV4 infected cells identified 
virus-induced changes to multiple cellular signaling pathways (34), several of which are 
important for efficient virus replication. These approaches are easily extendable to the study 
of HHV6A, as a genetically tractable BAC clone exists as well as an efficient in vitro lytic 
replication model.
Quantitative whole cell proteomics (qWCP) is another approach used to identify changes in 
host protein expression during viral infection. qWCP approaches most commonly use a mass 
spectrometer to identify either relative or absolute quantities of proteins in cell lysates under 
different conditions. Both relative and absolute qWCP approaches are standardized, and we 
Moorman and Murphy Page 4






















direct the reader to several method and review articles for additional details (35, 36). A 
modification of qWCP has also been developed that defines changes in cell surface proteins 
during infection (37). More recently whole cell proteomics coupled with transcript analysis 
has been used to identify and quantify the temporal expression of known and novel viral 
proteins (38). These studies have revealed that herpesvirus proteomes are far more complex 
than previously appreciated. Given the impact of proteomics on our understanding of 
herpesvirus protein function and genome complexity, applying these approaches to the study 
of roseoloviruses should rapidly increase our understanding of these complicated pathogens.
Metabolomics
Another –omics approach applied to the study of herpesvirus biology is metabolomics. The 
goal of metabolomics is to measure the abundance of all metabolites in a cell. Viruses are 
obligate intercellular pathogens that are directly reliant on host cell metabolites for anabolic 
processes; therefore herpesviruses must manipulate metabolic processes to support virus 
replication. Most metabolomics approaches utilize mass spectrometry to quantify a large 
number of metabolites from a single sample (reviewed in (39). Comparing the abundance of 
specific metabolites in virus-infected cells to that of mock-infected cells reveals critical 
virus-induced metabolic changes. Alternatively virus-induced changes to the rate of 
metabolism can be quantified by measuring the conversion of isotopically-labeled precursor 
metabolites such as glucose or glutamine into downstream metabolites.
Both approaches have been used to characterize how herpesvirus infection modulates 
metabolism. For example, both HHV-8 and HCMV increase aerobic glycolysis and 
stimulate fatty acid synthesis, reminiscent of the metabolic changes observed during 
oncogenesis (40–42). In contrast, HSV1 preferentially increases glucose metabolism by the 
pentose phosphate pathway, presumably to generate sufficient nucleotides for viral DNA 
replication (43). Fatty acid synthesis inhibitors limit HCMV replication (44) and the growth 
of primary effusion lymphomas associated with HHV-8 infection (45), and inhibitors of 
nucleotide metabolism decrease HSV1 replication (46). Therefore it is proposed that virus-
induced changes in metabolism are promising targets for new antiviral therapeutics (47).
Based on the critical role for metabolic remodeling in the lytic replication cycle of other 
herpesviruses, we hypothesize that roseoleviruses modulate host metabolic pathways in 
similar yet distinct ways to support efficient virus replication. Uncovering mechanisms of 
virus-induced metabolic remodeling will likely result in new targeted therapeutic 
interventions directed at roseoloviruses. Unfortunately almost nothing is known of the 
effects of roseolovirus infection on host cell metabolism. As such, current drugs used to treat 
roseolovirus infections are based solely on inferred functions putatively shared with other 
herpesviruses (48). While defining new viral functions to target with novel antivirals will 
likely require much effort, virus-induced changes in metabolism should be relatively 
straightforward to define. Therefore metabolomics analyses of roseolovirus infections 
present a promising direction in the identification of new therapeutics to limit roseolovirus 
pathogenesis.
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While we have described different –omics applications that are accessible to roseolovirus 
researchers, we, as a field, lack several resources needed to advance our understanding of 
roseolovirus biology to the level of its herpesvirus cousins. For HHV-6B and HHV-7, the 
lack of an infectious BAC clone is perhaps the most significant barrier to –omics 
approaches. The absence of HHV-6B and HHV-7 BAC clones severely limits our ability to 
perform both forward and reverse genetic screens to define the complement of viral factors 
important for roseolovirus disease. The BACs would also provide a convenient starting point 
to generate a library of expression vectors for roseolovirus ORFs. This library would be a 
high value resource for forward genetics screens, such as screens to identify viral proteins 
that regulate the innate and adaptive immune response. This is arguably the most significant 
roadblock to roseolovirus research.
We also lack a sufficient understanding of genetic diversity amongst roseoloviruses. A 
functional genomics analysis of circulating roseolovirus strains in distinct patient 
populations or locations would likely prove invaluable for identifying viral pathogenesis 
determinants. In addition such an analysis would facilitate the development of roseolovirus 
diagnostics. Current PCR-based diagnostics for the assessment of viral load in patient 
samples vary greatly in sensitivity between laboratories (49). This may reflect differences in 
the primers used for detection, methods of nucleic acid isolation and/or the choice of 
standardization protocols. However strain variability across different geographical regions 
could also account for these discrepancies. A thorough genomics analysis of strain variation 
for each roseolovirus would provide the starting point for the development of diagnostics 
targeting invariant regions of roseolovirus genomes. These data would also allow for the 
generation of suitable reference strains that are needed to standardize diagnostic assays.
The ability to efficiently map viral transcription in a tissue or viral lifecycle specific manner 
is critical to understanding how these viruses grow and cause disease. Due to the 
reproducibility, low cost, high sensitivity and high specificity of tiled arrays (50), 
development of virus-specific arrays for HHV-6A -6B and -7 should be prioritized. The 
production and use of tiled arrays is a standard commodity at most institutions and offers a 
unified platform for transcript characterization and quantification. In addition RNA-Seq and 
other next generation sequencing approaches can identify novel coding regions (51), small 
RNAs (52, 53) and/or splice junctions (54) in herpesvirus genomes that may expand the 
roseolovirus proteome. A combinatorial transcriptomic approach is a priority for defining 
the coding capacity and regulatory regions of roseolovirus genomes.
As with functional genomics, the ability to perform directed proteomics experiments to 
define the function of HHV-6B and HHV-7 proteins is severely hampered by the lack of 
infectious BAC clones. However such approaches should be easily applicable to the study of 
HHV-6A, as the necessary genetic system exists and the required reagents are commercially 
available. In addition, mass spectrometry core facilities capable of producing and analyzing 
the data from proteomics experiments are common at most research institutions. As with 
transcriptomics, a combination of proteomics approaches is needed to define novel viral 
coding determinants and their functions in order to identify new targets for antiviral drugs.
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While metabolomics is less common than other –omics approaches in the study of 
herpesviruses, metabolomics has already identified virus-induced metabolic changes that 
can be targeted with drugs. Metabolic perturbations underlie several disease states, and the 
development of drugs that regulate metabolism is an active area of clinical research. In some 
cases, metabolomics studies have suggested that currently approved drugs have been found 
to have novel antiviral activity (47), potentially speeding translation of these findings into 
the clinic. Metabolomics approaches should be relatively straightforward and thus should be 
prioritized.
The rapid development of –omics approaches over the last ten years has greatly changed our 
view of herpesvirus biology. As described above, many standard –omics approaches can be 
easily adapted for roseolovirus research, although for studies of HHV-6B and -7 some 
hurdles still remain. The lack of -omics approaches to date in roseolovirus research as a 
whole presents an opportunity for researchers to coordinate an integrated and highly targeted 
–omics analysis of these clinically important human pathogens.
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• High throughput protocols (“-omics”) have uncovered mechanisms of 
herpesvirus pathogenesis.
• Although increasingly common, “-omics” assessment of roseoloviruses has yet 
to be performed.
• Reagents exist to study HHV-6A but resources need to be developed to study 
HHV-6B and HHV-7.
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Figure 1. Schematic representation of high throughput system-wide analyses of roseolovirus 
pathogenic potential
The above is a listing of several available “-omics” analyses that are suited for profiling the 
impact of roseolovirus infection on host cells.
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